Previously, luteolin was reported to promote Nrf2 expression in HT29 colon cancer cells via the action of DNA demethylase, resulting in the enhanced interaction between Nrf2 and p53 that eventually led to apoptosis [213]. The gene discussed is NFE2L2; the disease is malignant colon neoplasm.